ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002

NCI Cooperative Group, Cancer Center Trials Listed

October 26, 2007

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

AACR Honors Scientists: Opens Web Sites

May 10, 1996

Cancer Groups Criticize Prescription Drug Bills.

June 27, 2003

In Brief: AACR, ASCO to Sponsor Joint Symposium on Oncogenes; AACI Hosts Congressional Staff

February 15, 1985